Exploiting reductive evolution in Mycobacterium ulcerans to develop a single-dose cure for Buruli ulcer
Summary Mycobacteria form one of the most successful human pathogens, with Mycobacterium tuberculosis causing tuberculosis and Mycobacterium leprae causing leprosy. Following the effective implementation of the BCG vaccine and the rigorous and conscious effort taken globally to curb tuberculosis an...
Saved in:
Main Author: | Sangeeta, Susan Thomas |
---|---|
Other Authors: | Kevin Pethe |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2021
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/152336 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Toward a single-dose cure for buruli ulcer
by: Thomas, Sangeeta Susan, et al.
Published: (2021) -
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
by: Chauffour, Aurélie, et al.
Published: (2021) -
Single-dose radical cure of Plasmodium vivax: A step closer
by: Ric N. Price, et al.
Published: (2018) -
Sensitivity of mycobacterium leprae to telacebec
by: Lahiri, Ramanuj, et al.
Published: (2022) -
Low-dose cimetidine in the acute treatment of duodenal ulcer. Comparison of a single nocturnal dose regimen with a twice daily regimen.
by: Kang, J.Y., et al.
Published: (2014)